Searched for
RNA
To win the deep-tech race, India needs ‘General Innovation Rules’India is launching ambitious science initiatives. However, current financial rules designed for conventional procurement hinder R&D. A new ...- Could protein 'traffic jams' be the key to understanding aging and Alzheimer's? Here's what Stanford scientists claimStanford University researchers have identified a breakdown in the cell's protein production system as a key factor in brain aging and cogn...
- Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...
- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
- Gene therapy for cholesterol: Initial test results cheerA new gene editing medicine, VERVE-102, offers hope for millions with heart conditions. Eli Lilly's drug showed significant reductions in b...
- Vikas Khemani-backed Q-Line Biotech IPO subscribed over 2 times on Day 1 as GMP soars to 42%Vikas Khemani-backed Q-Line Biotech's IPO opened on Wednesday, aiming to raise up to Rs 214.48 crore on NSE Emerge. The company, operating ...
- Tooth regeneration therapy enters first human clinical trials in JapanA groundbreaking human trial in Japan is exploring a revolutionary treatment to regrow teeth. Researchers have identified a way to activate...
- Moderna first-quarter revenue jumps on strong overseas COVID vaccine salesModerna's first-quarter revenue surpassed estimates, driven by strong international COVID-19 vaccine sales. The company forecasts lower-tha...
- Moderna stocks: MRNA shares jump in US Stock market today after pharma giant surpasses Wall Street estimatesModerna had earlier posted a loss of $2.52 per share a year earlier, while analysts expected a loss of $3.96 per share.
- Scientists Identify the Main Cause of Sunburns, and Now They Have to Update the TextbooksA groundbreaking study reveals a new cause for sunburn's immediate pain. Scientists now believe damage to RNA, not DNA, triggers the rapid ...
- Have machine in the loop: It is time to flip the human-in-the-loop modelTwo stories highlight how AI can empower rather than replace humans. In one, a software engineer used tools like ChatGPT and AlphaFold, alo...
- Why Your Kitchen Sponge Might Be Making Everything Smell WorseYour kitchen sponge, a cleaning essential, harbors billions of bacteria. Research reveals these porous tools become microbial hotspots, bre...
- Man with no medical degree creates cancer vaccine using ChatGPT for his sick pet. Open AI CEO Sam Altman reacts: ‘This should be easy ….’An Australian businessman, Paul Conyngham, used AI tools like ChatGPT and AlphaFold to develop a personalized mRNA cancer treatment for his...
- The Animal That Edits Its Own Genes After They’re WrittenOctopuses possess a unique ability to rewrite their genetic messages. They extensively edit RNA after its creation, altering instructions b...
- mRNA vaccine against tuberculosis shows efficacy in mice, results pave way for larger trialsAustralian researchers have developed a new mRNA vaccine for tuberculosis, showing effective results in mice. The vaccine enhances immunity...
- What is microRNA? All about Victor Ambros and Gary Ruvkun's discovery which won them Nobel Prize in Medicine 2024Scientists Victor Ambros and Gary Ruvkun won the 2024 Nobel Prize in Physiology or Medicine for discovering microRNA and its role in gene r...
- Emcure and its subsidiary Gennova settle legal dispute with HDT Bio over mRNA technologyEmcure Pharmaceuticals and its subsidiary Gennova have resolved all legal disputes with US-based HDT Bio Corp. The parties have entered int...
- CEPI to fund Gennova's self amplifying mRNA vaccine against Disease XThe Coalition for Epidemic Preparedness Innovations (CEPI) and Gennova Biopharmaceuticals have announced a new funding agreement to develop...
- Biological E to get mRNA technology from WHO to make COVID-19VaccinesWHO along with its partners will work with the Indian government and BE to develop a roadmap and put in place the necessary training and su...
- A cure for cancer: After Covid vaccine, next mRNA miracle might be closer than you imagineThe new technology was not only lightning fast but also incredibly effective - mRNA Covid vaccines from both Moderna and Pfizer hit the bul...
Load More
